Trial Profile
Prospective, Open-label, Multi-centre Phase 3b Study to Assess the Efficacy and Safety of Personalized Prophylaxis With Human-cl rhFVIII in Previously Treated Adult Patients With Severe Haemophilia A
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Simoctocog alfa (Primary)
- Indications Haemophilia A
- Focus Registrational; Therapeutic Use
- Sponsors Octapharma
- 30 May 2019 This trial has been completed in Croatia, according to European Clinical Trials Database.
- 22 Mar 2019 This trial has been completed in Slovenia, according to European Clinical Trials Database.
- 22 Mar 2019 This trial has been completed in Netherlands, according to European Clinical Trials Database.